On 8 December 2017
Parmax Pharma will hold a meeting of the Board of Directors of the Company on 8 December 2017, to consider, approve and take on record Unaudited Financial Results for the quarter and half year ended 30th September 2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
